Micro Labs Launches Sitanorm E: Sitagliptin + Empagliflozin FDC for diabetes patients in India Deeksha Bhandari26 May 2025 11:40 AM ISTMicro Labs has announced the launch of Sitanorm-E, a fixed-dose combination (FDC) of Sitagliptin and Empagliflozin for the management of ...
Post-Patent Expiry Boom, Empagliflozin Sees Brand Flood, 147 Brands Launched: Pharmatrac Farhat Nasim9 May 2025 7:51 PM ISTEmpagliflozin plain and its combination with Linagliptin currently account for about 80% of total sales in this Rs 745 crore market.
NPPA fixes ceiling prices for 84 drug formulations; focus on Empagliflozin-based Diabetes therapies Ruchika Sharma8 May 2025 2:14 PM ISTNew Delhi: In a fresh directive aimed at curbing treatment costs and improving access to essential medicines, the National Pharmaceutical Pricing...
Right Turn Show- Exploring Dapagliflozin Beyond Glycemic Benefits Deeksha Bhandari8 April 2025 12:34 PM ISTIn the last episode, we explored the role of Dapagliflozin in specialty care settings. Moving forward, this episode delves into Dapagliflozin Beyond...
Dapagliflozin Sitagliptin-Preferred SGLT2i-DPP4i FDC in Indian Clinical Practice Dr. Saptarshi Bhattacharya7 April 2025 11:34 AM ISTType 2 diabetes mellitus (T2DM) is a major public health challenge in India, with an estimated 101 million individuals affected and 39.4 million...
USV Launches Empagliflozin Range Under Xenia Brand Deeksha Bhandari2 April 2025 12:23 PM ISTUSV Pvt. Ltd., a leader in diabetes care, has announced the launch of its Xenia brand range in India, following the patent expiry of Empagliflozin. ...
USV Launches Xenia Brand Range Following Empagliflozin Patent Expiry Deeksha Bhandari21 March 2025 6:00 PM ISTNew Delhi: Strengthening its leadership in diabetes care, USV Pvt. Ltd. has announced the launch of its Xenia brand range, following...
Exemed Pharmaceutical Gets CDSCO Panel Nod To Manufacture Market Antidiabetic FDC Dr. Divya Colin7 March 2025 6:00 PM ISTNew Delhi: Exemed Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Use of Generic DPP4i + SGLT2i FDCs by Indian Physicians - The DiSi Survey Dr. Garima Soni19 Feb 2025 11:28 AM ISTThe Indian phenotype of T2DM patients is associated with clustering of cardiovascular risk factors, increased insulin resistance, and reduced...
CVS Caremark to add Zydus Zituvio, combination products to its template formulary Ruchika Sharma7 Jan 2025 4:00 PM ISTAhmedabad: Zydus Lifesciences Ltd, a global healthcare company announced that it has entered into an agreement with CVS Caremark, a CVS...
Right Turn Show - Decoding the Use of Dapagliflozin and its Combinations with Metformin and Sitagliptin in Specialty Care Settings MD Brand Connect18 Dec 2024 12:00 PM ISTPresenting Episode 2 of the Right Turn Show, in this episode, insights from leading experts are explored on the practical application of dapagliflozin...
Lupin gets tentative USFDA nod for Sitagliptin, Metformin Hydrochloride Tablets to treat type 2 diabetes Ruchika Sharma29 Nov 2024 3:32 PM ISTMumbai: Global pharma major Lupin Limited today announced that it has received tentative approval from the United States Food and Drug Administration...
